Thomas N. Krausz to Neoplasms
This is a "connection" page, showing publications Thomas N. Krausz has written about Neoplasms.
Connection Strength
0.187
-
Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial. Clin Cancer Res. 2020 12 15; 26(24):6437-6444.
Score: 0.066
-
BAP1 and cancer. Nat Rev Cancer. 2013 03; 13(3):153-9.
Score: 0.039
-
Expression and mutational analysis of MET in human solid cancers. Genes Chromosomes Cancer. 2008 Dec; 47(12):1025-37.
Score: 0.029
-
Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med. 2005 Mar 07; 201(5):779-91.
Score: 0.022
-
Strong synergy between mutant ras and HPV16 E6/E7 in the development of primary tumors. Oncogene. 2004 May 13; 23(22):3972-9.
Score: 0.021
-
p53 immunostaining as a marker of malignant disease in diagnostic cytopathology. Lancet. 1991 Aug 24; 338(8765):513.
Score: 0.009
-
Antibody-guided irradiation of malignant pleural and pericardial effusions. Br J Cancer. 1986 Jun; 53(6):727-32.
Score: 0.002